AngioDynamics Reports Fiscal 2021 Second Quarter Financial Results

Go back to AngioDynamics Reports Fiscal 2021 Second Quarter Financial Results

AngioDynamics (ANGO) Tops Q2 EPS by 3c, Revenues Beat; Offers FY21 EPS/Revenues

January 7, 2021 7:10 AM EST

AngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.01, $0.03 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $72.8 million versus the consensus estimate of $67.35 million.

Fiscal 2021 Second Quarter Highlights

Net sales of $72.8 million increased 4.0% compared to the prior-year quarterGross margin declined 410 basis points year over year to 55.2%GAAP loss per share of $0.11 and adjusted earnings per share of $0.01Cash and cash... More